TickerKhojAARTIDRUGS · Pharmaceuticals
Aarti Drugs Limited
- Company snapshot
- 2026-11-05
- Latest available quarter
- 2026-09-30Consolidated
- Ownership quarter
- 2026-09-30
COMPANY COMPARISON · NSE
AARTIDRUGS vs EVONILE
Compare business size, valuation, growth and ownership. Higher or lower does not automatically mean better.
EVONILE · Pharmaceuticals
Evonile Pharma Limited
- Company snapshot
- 2026-11-05
- Latest available quarter
- Not suppliedReporting basis not supplied
- Ownership quarter
- Not supplied
Side by side
Choose a metric group. Tap a metric’s explanation button for context.
19 metrics shown
| Metric | AARTIDRUGS | EVONILE |
|---|---|---|
| Price | ₹445.15 | ₹1,716.5 |
| Market cap | ₹4,148 cr | ₹4,288 cr |
| P/E | 17.8 | — |
| P/B | 2.4 | 5.5 |
| ROE | 13.4% | 11.6% |
| ROCE | 13.2% | 11.8% |
| Debt / equity | 0.37 | 0 |
| Operating margin | 10.9% | 12.1% |
| Dividend yield | 0.44% | 1.44% |
| Sales growth, 3 years (yearly) | -2.0% | -2.2% |
| Profit growth, 3 years (yearly) | 5.4% | -3.4% |
| 1-year return | -11.6% | 0.4% |
| Revenue, last 12 months | ₹2,851 cr | ₹336 cr |
| Net profit, last 12 months | ₹229 cr | ₹-4 cr |
| Latest available quarter | Sept 2026 | — |
| Quarter net profit | ₹83 cr | — |
| Quarter profit vs a year earlier | +83.2% | — |
| Promoter holding | 54.07% | — |
| Health check | Strong (6.6/10) | Weak (2/10) |